Dewpoint Therapeutics Announces DPTX3496 as a Development Candidate for the Treatment of Colorectal, Breast, and Lung Cancers
Dewpoint Therapeutics’ second development candidate, DPTX3496 is an oral, small molecule acting via a novel ...
Ukrainian drone strike sets Russian oil, gas plants ablaze, officials say
A Russian oil refinery and gas processing plant went up in flames after Ukraine fired dozens of drones over the border Sunday ...
Business Insider12d
Dewpoint Therapeutics Announces DPTX3496 as a Development Candidate for the Treatment of Colorectal, Breast, and Lung Cancers
inhibits beta catenin’s aberrant transcriptional activity by sequestering beta catenin into nuclear condensate depots. This sequestration takes advantage of a condensate-mediated mechanism of ...
Mena FN12d
Dewpoint Therapeutics Announces DPTX3496 As A Development Candidate For The Treatment Of Colorectal, Breast, And Lung Cancers
DPTX3496, which was discovered and optimized using Dewpoint's proprietary platform , inhibits beta catenin's aberrant transcriptional activity by sequestering beta catenin into nuclear condensate ...